Compounds > pk 11195
Page last updated: 2024-10-21

pk 11195 and Chronic Progressive Multiple Sclerosis

pk 11195 has been researched along with Chronic Progressive Multiple Sclerosis in 2 studies

PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kang, Y2
Pandya, S1
Zinger, N1
Michaelson, N1
Gauthier, SA2
Schlyer, D1
Kaunzner, UW1
Kuceyeski, A1
Kothari, PJ1

Other Studies

2 other studies available for pk 11195 and Chronic Progressive Multiple Sclerosis

ArticleYear
Longitudinal change in TSPO PET imaging in progressive multiple sclerosis.
    Annals of clinical and translational neurology, 2021, Volume: 8, Issue:8

    Topics: Adult; Female; Gray Matter; Humans; Isoquinolines; Longitudinal Studies; Male; Middle Aged; Multiple

2021
Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11]PK11195.
    PloS one, 2018, Volume: 13, Issue:8

    Topics: Adult; Brain; Female; Humans; Image Processing, Computer-Assisted; Isoquinolines; Magnetic Resonance

2018